Navigation Links
Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events
Date:6/13/2008

Paris, France, Friday 13 June 2008: Certain cardiovascular disease (CVD) risk factors and rheumatoid arthritis (RA) disease factors have a similar effect on an RA patient's risk of experiencing myocardial infarction (MI) or stroke, according to a new study presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

The researchers studied 10,870 RA patients for a median of 24 months across two cohorts - patients with active RA and those with prior experience of CVD. Cox regression models revealed that the CVD risk factors leading to an increased relative risk of MI or stroke were: non-Caucasian ethnicity (relative risk (RR) 1.26), body mass index (RR 1.25), prior MI (RR 1.75), and any current tobacco use (RR 1.92). The RA disease factors leading to an increased relative risk of MI or stroke were: nodules (RR 1.44), Health Assessment Questionnaire Disability Index (HAQ-DI) (RR 1.20 per each point increase) and the Clinical Disease Activity Index (CDAI) (RR 1.06 per each point increase). The area under the receiver operating characteristic curve (c-statistic) of the CVD risk factor and RA disease factor models (adjusting for age and gender) were both calculated as 0.75, demonstrating a comparable relationship with CVD endpoints for both RA and CVD risk factors..

Lead investigator, Professor Daniel H Solomon of Brigham and Women's Hospital and Harvard Medical School, Boston, USA, said: "It has been established that people with RA are more likely to experience cardiovascular disease or complications than the general population, but our research examines the importance of RA-specific factors compared with traditional cardiovascular risk factors. We have shown that having more high risk RA-specific risk factors increases the CVD risk to a rate similar to that of traditional cardiovascular risk factors. We hope that the results of our study lead to more robust clinical prediction rules for CVD o
'/>"/>

Contact: Rory Berrie / Camilla Dormer
eularpressoffice@uk.cohnwolfe.com
44-077-892-70392
European League Against Rheumatism
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
2. HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
3. Hand bone mineral density is an effective predictor of mortality in rheumatoid arthritis
4. Biogen Idecs baminercept alfa shows promise in patients with rheumatoid arthritis
5. Golimumab Eases Rheumatoid Arthritis Symptoms
6. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
7. Drinking Cuts Rheumatoid Arthritis Risk
8. Regular tipple may curb risk of rheumatoid arthritis
9. American College of Rheumatology presents recommendations for rheumatoid arthritis therapy
10. Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate
11. Breast-feeding Might Shield Women From Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Wailea, Maui, HI (PRWEB) July 29, 2014 ... Four Seasons Resort Maui at Wailea. This September through ... many of them free-- tailored to couples of all ages ... great and guests can take advantage of the Resort's popular ... to $1,000 while the "twice yearly sale" is in full ...
(Date:7/29/2014)... Tucson-based company Outski has created a ... and wellness program, called 401(play)™. A 401(play)™ plan promotes ... for employees to use their earned vacation time. In ... the amount of each paycheck to be put into ... offering a 401(play)™ plan to in several ways; for ...
(Date:7/29/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:7/29/2014)... Dallas, Texas (PRWEB) July 29, 2014 Guests ... , will be indulged in a new sleep experience. The ... INTENTIONS™ Linens by Peacock Alley. , These expertly crafted, ... simple striped pattern from a distance, yet upon closer look, ... gentle reminders to relax, sleep and breathe. , ...
(Date:7/29/2014)... The Multiple System Atrophy Coalition, a growing nonprofit ... five new members to its Board of Directors. ... its executive directors. The MSA Coalition now has ... Advisors. These 12 dedicated volunteers are fully focused ... advocacy and research funding for the neurological disorder Multiple ...
Breaking Medicine News(10 mins):Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 3Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4
... Wound Care,Innovations, LLC, a subsidiary of Wound ... the 510k clearance of a new wound,management product ... new addition to our product line (patent pending) ... (PSGAG) and will initially be available in gel ...
... Cord Blood,America, Inc. (OTC Bulletin Board: CBAI), the ... ) focused on,bringing the life saving potential of ... that a letter to shareholders from CEO Matthew,Schissler ... letter explains,some of the positive scientific and economic ...
... Corgenix Medical Corporation,(OTC Bulletin Board: CONX), a ... sales of $2,001,896 for the first fiscal,quarter ended ... quarter,ended September 30, 2007, a decrease of 4.9%. ... over the same period,in the prior fiscal year., ...
... China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- China,Information Security ... Information,Security," "CIST" or the "Company"), a leading ... Information,Systems ("GIS") solutions provider to public security ... for 2009., China Information Technology has ...
... people choose to get representation when they apply for SSDI, a ... ... Belleville, IL (Vocus) November 13, 2008 -– Difficult decisions ... and one of the most important is how to begin the ...
... Nov. 13 TheraQuest Biosciences, Inc. a,development ... the U.S.,Food and Drug Administration (FDA) has ... TQ-1015, its abuse deterrent extended release,strong opioid. ... abuse deterrent technology., Najib Babul, PharmD, ...
Cached Medicine News:Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 2Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 3Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 3Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 2Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 4Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 2Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 3Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 4Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 6Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2
(Date:7/29/2014)... --   Glide Pharmaceutical Technologies ... an exclusive worldwide licence to an innovative prostate cancer ... University spin-out company.  Under the terms of ... development and commercial milestone payments, and royalties on future ... for additional exclusive licences to FScan diagnostic technologies, for ...
(Date:7/29/2014)... --   , First patient begins ... and safety of MSB0010718C in patients with metastatic Merkel cell ... skin cancer lacking effective treatments   MSB0010718C is also ... trial for the treatment of solid tumors that aims to ... subsidiary of Merck KGaA, Darmstadt, Germany , ...
(Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
Breaking Medicine Technology:Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2
... Prostate Conditions Education Council (PCEC) – a ... in prostate cancer screening – today announced it strongly ... Services Task Force (USPSTF). The draft guidance recommends against ... PCEC believes that until a more accurate and ...
... 10, 2011 PDI, Inc. (Nasdaq: ... R. Melillo, Jr. as senior vice president of Business ... drive PDI,s commercial outsource services and contract sales business. ... officer. Melillo was most recently general manager ...
Cached Medicine Technology:Prostate Conditions Education Council Opposes U.S. Preventative Services Task Force Recommendation 2Prostate Conditions Education Council Opposes U.S. Preventative Services Task Force Recommendation 3PDI Appoints Gerald R. Melillo, Jr. As SVP of Business Development 2
... rub formula is the most convenient multi-purpose ... in one bottle without the need to ... contact lenses and removes protein build-up when ... that contains Hydranate, a special ingredient that ...
Grafton Trial Frame...
The award-winning new Universal Trial Frame (UB4), the ergonomic refraction design from Oculus that's easier to use, easier to wear....
Half Eye Trial Frame - Adult...
Medicine Products: